The effect of an ovalbumin protein hydrolysate on muscle strength recovery in athletes

Completed

Conditions: kracht/spierherstel in sporters na krachtspecifieke training
Overtraining
strength recovery

Registration Number: NL-OMON43531

Lead Sponsor: BioActor B.V.

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: Not specified

Target Recruitment: 48

Inclusion Criteria

Health individuals (men/women). Participants are amateur or (semi-)professional athletes (engage in >6 hours of intense physical activity per week). Age 18-35. Participants are experienced in resistance training.

Exclusion Criteria

- Use of creatine supplements and/or anabolic steroids.
- Allergy to test product/protein
- Allergy to chicken protein
- BMI lower than 18 or higher than 30
- Lack of technique in correctly performing a barbell squat (judged by sports physiologist).
- Recent muscle injury in leg or back less than one month before the start of the study.
- Cardiovascular complications
- Use of medication that may interfere with the study outcomes
- Administration of investigational drugs or participation in any scientific intervention study which may interfere with this study (to be decided by the principle investigator), in the 180 days prior to the study.
- Abuse of products; alcohol (> 20 alcoholic units per week) and drugs.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary efficacy parameter of the study is to determine the dose-dependent<br /><br>effect of ovalbumin hydrolysate supplementation between two experimental groups<br /><br>compared to placebo for a period of 4 weeks on muscle peak force recovery after<br /><br>high intensity resistance exercise.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary endpoints entail the evaluation of dose-dependent effects of daily<br /><br>administration ovalbumin hydrolysate on blood lactate (finger prick), body<br /><br>composition (skin fold measurements), exercise volume, anaerobic capacity, peak<br /><br>force output and delayed onset muscle soreness scores between two experimental<br /><br>groups compared to placebo after a period of 4 weeks.</p><br>